Zioptan 0.015 MG/ML Ophthalmic Solution
- RxCUI
- 1244616
- RxNorm name
- Zioptan 0.015 MG/ML Ophthalmic Solution
- Display name
- Zioptan 0.015 MG/ML Ophthalmic Solution
- Full name
- Zioptan 0.015 MG/ML Ophthalmic Solution
- Term type
- SY
- Status
- DailyMed mapping
- Updated
- 2026-06-04 23:39:11
UNII Substances#
No records found.
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| ZIOPTAN | TAFLUPROST | Thea Pharma Inc. | db529b54-2ac7-4020-9791-7333bbe6c90f | 2026-04-23 | Adverse reactions | 1244616 |
DailyMed RxNorm Mappings#
| Set ID | RxNorm string | TTY | SPL version | Label | Effective |
|---|---|---|---|---|---|
| a3173c26-0e19-47af-a01c-3fc06b2700d1 | Zioptan 0.015 MG/ML Ophthalmic Solution | SY | 10 | These highlights do not include all the information needed to use ZIOPTAN ® (tafluprost ophthalmic solution) 0.0015% safely and effectively. See full prescribing information for ZIOPTAN ® . ZIOPTAN ® (tafluprost ophthalmic solution) 0.0015% Initial U.S. Approval: 2012 | 20221004 |
| a3173c26-0e19-47af-a01c-3fc06b2700d1 | Zioptan 0.0015 % Ophthalmic Solution | SY | 10 | These highlights do not include all the information needed to use ZIOPTAN ® (tafluprost ophthalmic solution) 0.0015% safely and effectively. See full prescribing information for ZIOPTAN ® . ZIOPTAN ® (tafluprost ophthalmic solution) 0.0015% Initial U.S. Approval: 2012 | 20221004 |
| a3173c26-0e19-47af-a01c-3fc06b2700d1 | ZIOPTAN 0.0015 % Ophthalmic Solution | PSN | 10 | These highlights do not include all the information needed to use ZIOPTAN ® (tafluprost ophthalmic solution) 0.0015% safely and effectively. See full prescribing information for ZIOPTAN ® . ZIOPTAN ® (tafluprost ophthalmic solution) 0.0015% Initial U.S. Approval: 2012 | 20221004 |
| a3173c26-0e19-47af-a01c-3fc06b2700d1 | Zioptan 0.0045 MG in 0.3 ML Ophthalmic Solution | SY | 10 | These highlights do not include all the information needed to use ZIOPTAN ® (tafluprost ophthalmic solution) 0.0015% safely and effectively. See full prescribing information for ZIOPTAN ® . ZIOPTAN ® (tafluprost ophthalmic solution) 0.0015% Initial U.S. Approval: 2012 | 20221004 |
| a3173c26-0e19-47af-a01c-3fc06b2700d1 | tafluprost 0.015 MG/ML Ophthalmic Solution [Zioptan] | SBD | 10 | These highlights do not include all the information needed to use ZIOPTAN ® (tafluprost ophthalmic solution) 0.0015% safely and effectively. See full prescribing information for ZIOPTAN ® . ZIOPTAN ® (tafluprost ophthalmic solution) 0.0015% Initial U.S. Approval: 2012 | 20221004 |
| db529b54-2ac7-4020-9791-7333bbe6c90f | ZIOPTAN 0.0015 % Ophthalmic Solution | PSN | 7 | These highlights do not include all the information needed to use ZIOPTAN ® (tafluprost ophthalmic solution) 0.0015% safely and effectively. See full prescribing information for ZIOPTAN ® . ZIOPTAN ® (tafluprost ophthalmic solution) 0.0015% Initial U.S. Approval: 2012 | 20260423 |
| db529b54-2ac7-4020-9791-7333bbe6c90f | Zioptan 0.015 MG/ML Ophthalmic Solution | SY | 7 | These highlights do not include all the information needed to use ZIOPTAN ® (tafluprost ophthalmic solution) 0.0015% safely and effectively. See full prescribing information for ZIOPTAN ® . ZIOPTAN ® (tafluprost ophthalmic solution) 0.0015% Initial U.S. Approval: 2012 | 20260423 |
| db529b54-2ac7-4020-9791-7333bbe6c90f | Zioptan 0.0015 % Ophthalmic Solution | SY | 7 | These highlights do not include all the information needed to use ZIOPTAN ® (tafluprost ophthalmic solution) 0.0015% safely and effectively. See full prescribing information for ZIOPTAN ® . ZIOPTAN ® (tafluprost ophthalmic solution) 0.0015% Initial U.S. Approval: 2012 | 20260423 |
| db529b54-2ac7-4020-9791-7333bbe6c90f | Zioptan 0.0045 MG in 0.3 ML Ophthalmic Solution | SY | 7 | These highlights do not include all the information needed to use ZIOPTAN ® (tafluprost ophthalmic solution) 0.0015% safely and effectively. See full prescribing information for ZIOPTAN ® . ZIOPTAN ® (tafluprost ophthalmic solution) 0.0015% Initial U.S. Approval: 2012 | 20260423 |
| db529b54-2ac7-4020-9791-7333bbe6c90f | tafluprost 0.015 MG/ML Ophthalmic Solution [Zioptan] | SBD | 7 | These highlights do not include all the information needed to use ZIOPTAN ® (tafluprost ophthalmic solution) 0.0015% safely and effectively. See full prescribing information for ZIOPTAN ® . ZIOPTAN ® (tafluprost ophthalmic solution) 0.0015% Initial U.S. Approval: 2012 | 20260423 |